Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuronetics (STIM) Change in Cash (2017 - 2025)

Historic Change in Cash for Neuronetics (STIM) over the last 9 years, with Q3 2025 value amounting to $17.0 million.

  • Neuronetics' Change in Cash rose 17808.04% to $17.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.6 million, marking a year-over-year increase of 19081.44%. This contributed to the annual value of -$40.2 million for FY2024, which is 27717.34% down from last year.
  • Latest data reveals that Neuronetics reported Change in Cash of $17.0 million as of Q3 2025, which was up 17808.04% from -$3.8 million recorded in Q2 2025.
  • Over the past 5 years, Neuronetics' Change in Cash peaked at $72.3 million during Q1 2021, and registered a low of -$21.8 million during Q3 2024.
  • Its 5-year average for Change in Cash is -$762421.1, with a median of -$5.3 million in 2021.
  • Examining YoY changes over the last 5 years, Neuronetics' Change in Cash showed a top increase of 80964.86% in 2023 and a maximum decrease of 46349.84% in 2023.
  • Over the past 5 years, Neuronetics' Change in Cash (Quarter) stood at -$5.3 million in 2021, then surged by 36.56% to -$3.4 million in 2022, then skyrocketed by 809.65% to $23.8 million in 2023, then tumbled by 105.91% to -$1.4 million in 2024, then surged by 1307.53% to $17.0 million in 2025.
  • Its Change in Cash stands at $17.0 million for Q3 2025, versus -$3.8 million for Q2 2025 and $1.8 million for Q1 2025.